Unzue explained that 10% of the money will go to the Luzón Foundation, 40% (€1.5 million) to the European TRICALS platform made up of researchers, associations and charities working to promote clinical trials on ALS, and the remaining 50% (€2.3 million) will be given out as “Unzué-Luzón-Areces” research grants.